Organigram (TSE:OGI) Shares Down 11% – Should You Sell?

Organigram Holdings Inc. (TSE:OGI)’s share price traded down 11% on Tuesday . The stock traded as low as C$2.34 and last traded at C$2.35. 468,003 shares changed hands during mid-day trading, an increase of 131% from the average session volume of 202,513 shares. The stock had previously closed at C$2.64.

Organigram Trading Up 0.8%

The company has a debt-to-equity ratio of 3.07, a current ratio of 3.36 and a quick ratio of 2.62. The business has a fifty day moving average of C$2.33 and a 200-day moving average of C$2.23. The stock has a market capitalization of C$324.05 million, a price-to-earnings ratio of -12.42, a price-to-earnings-growth ratio of 0.42 and a beta of 2.22.

Insider Activity at Organigram

In related news, insider Helen Martin sold 12,848 shares of the stock in a transaction on Tuesday, October 21st. The stock was sold at an average price of C$2.49, for a total value of C$31,991.52. Following the completion of the transaction, the insider owned 47,511 shares in the company, valued at C$118,302.39. This trade represents a 21.29% decrease in their position. Also, insider Timothy Emberg sold 12,409 shares of the business’s stock in a transaction dated Tuesday, October 21st. The stock was sold at an average price of C$2.49, for a total value of C$30,898.41. Following the sale, the insider owned 46,110 shares in the company, valued at approximately C$114,813.90. The trade was a 21.21% decrease in their position. Insiders sold 161,555 shares of company stock valued at $385,351 over the last ninety days. Company insiders own 31.32% of the company’s stock.

Organigram Company Profile

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.